Immunosuppressants may be applied topically to mucosal surfaces for treating inflammatory diseases, e.g, vulvar lichen planus and Behcet's disease. The efficacy ofthe treatment is dependent on the potency of the drug and its penetration into the tissue. In this study the in vitro diffusion characteristics ofTacrolimus (Tac) and Cyclosporin A (CsA) across human vaginal mucosa are investigated and compared. Fresh human vaginal mucosa was snap-frozen in liquid nitrogen and stored at -85°C, Prior to an experiment, the tissue was defrosted to 20°C in PBS buffer, pH 7.4, and placed in the seven flow cells of a flow-through perfusion apparatus. Either tritiated Tae, or CsA, was then pipetted into the donor chamber of the flow cell. Samples from each flow cell were collected every 2 hours (1.5 ml/h) over a 24-hour period. Statistical analyses were carried out using an F-test. CsA and Tac flux values progressively increased throughout the 24-hour period, and steady state was not reached for either drug. The mean estimated flux values (mean at 16,20 and 24 h) forTac (599±44 dpm.cmvmln') were greater than those for CsA(96 ± 5.0 dpm, cmvmin"). Whole curve comparison indicated statistically significant differences (P = 1.77xl0· 163 ) .
Immunosuppressive drugs are the most predominant and successful form of treatment for autoimmune diseases and prevention of transplant rejection. Most of these drugs act by reducing the production of lymphocytes. Both tacrolimus (Tac), a hydrophobic macrolide (Mw = 822 Da), and cyclosporin A (CsA), a cyclic oligopeptide (Mw = 1202 Da), are ca1cineurin inhibitors which act by binding to immunophilins (Tac binds to FK binding protein and CsA to cyclophilin), causing inhibition ofca1cineurin, a ca1cium/calmodulindependent serine/threonine protein phosphatase (l). Ca1cineurin is integral in regulating the entire immune response involved in graft rejection because of the important role it plays in the proliferation and activation of T-cells by promoting transcription of interleukin-2 (l). In vitro studies, have shown Tac to be 10 -100 times more potent than CsA for inhibiting IL2 production, T-cellproliferation and production of other growth-promoting cytokines (2) .
Both Tac and CsA are primarily used systemically for prophylaxis of graft rejection following allogenic organ transplants. However, disorders such as rheumatoid arthritis, uveitis (3), oral lichen planus (4), inverse psoriasis (5) and atopic dermatitis (6) (7) have all been successfully treated with Tac. Systemic administration of CsA has also been shown to be an effective form of treatment for atopic dermatitis, psoriasis, pyoderma gangrenosum and other dermatological disorders (8) .
Unfortunately, the systemic use of both immunosuppressants may give rise to a wide variety of adverse effects. Topical application of these drugs could therefore be a means to circumvent these adverse effects by providing a more site-specific action. Other advantages oftopical drug application include avoiding pre-systemic metabolism in the gastrointestinal tract and hepatic first pass effects. Site-specific immunosuppression with topical CsA (9) and Tac could have extensive clinical applications in the treatment of skin disorders like lichen planus, psoriasis, pyoderma gangrenosum and cutaneous graft-versus-host disease. Additionally, it has also been demonstrated that the use of Tac instead of topical steroids, for the treatment of atopic eczema, does not thin the skin in the way that steroids do, making it a much more suitable alternative for use on facial areas. More recently, topical Tac has been reported to be a successful treatment of genital lichen sclerosis (LS) in three different groups (10) .
Several autoimmune or inflammatory conditions of the buccal, or vaginal mucosa are characterised by clinically distinct lesions. The latter are often accompanied by sloughing off of the epithelium, thus rendering the damaged mucosa potentially more permeable to drugs (11) . A comparative study of human vaginal and buccal epithelium (12) , showed similarities between the two tissue types that support the use of the former as a substitute for the latter mucosa. The similarity in permeability of these two tissue types to a range of permeants has also been demonstrated in various other studies (13) (14) . In vitro permeability characteristics of drugs through one of these mucosa may therefore be extrapolated to the other with a high degree of confidence.
In view of the potentially useful applications of the topical administration of these two immunosuppressants for a variety of clinical conditions, the aim of the present study is to assess the comparative permeability of intact and deepithelialised human vaginal mucosa to Tac and CsA.
MATERIALS AND METHODS

Human vaginal mucosa
Tissue specimens were obtained from excess tissue removed from seven postmenopausal women (ages: 60 ± 10 y) subsequent to vaginal hysterectomies at the Louis Leipoldt Hospital, Bellville, South Africa.
Permeability experiments
Prior to the start of each experiment, frozen tissue specimens were thawed to room temperature (20°C) in phosphate buffered saline (PBS, pH 7.4). Thereafter, they were cut into 7 pieces, approximately 4 mm-each, and mounted on small discs to be placed into the flow cells of the flow-through diffusion apparatus (exposed areas 0.039 cm-). Permeation studies were performed on 7 tissue replicates each, for both Tac and CsA. For the Tac experiments, 3.5 JlI Tac (1 JlCi/JlI) was diluted into 3.5 ml PBS; 11.7 JlI CsA (I JlCi/JlI) was diluted in 3.5 ml PBS for the CsA experiments. These solutions (0.5 ml) were then pipetted into the donor compartment of each flow cell. All radioisotopes were obtained from Amersham Laboratories (Little Chalfont, Amersham, UK). Within minutes, 100 JlI aliquots were removed from the 7 donor compartments to determine the donor cell concentration at zero time. For 24 h, PBS at 20°C was pumped at a rate of 1.5 ml/h through the acceptor chambers. Samples were collected every 2 h by means of a fraction collector. For the purposes of this study, the samples at 2, 4,8, 12, 16, 20 and 24 h were used. To each of these samples, 10 ml of scintillation cocktail (Ready Protein-?'; Beckman Instruments, Fullerton, CA, USA) was added. The radioactivity was determined using a liquid scintillation counter (Beckman LS 5000TD).
De-epithelialisation
For this study we followed two methods to remove the epithelium from the vaginal mucosa. The first, mechanical de-epithelialisation was performed by using a scalpel to scrape off the uppermost layer from the vaginal mucosa specimens. The second method, heat de-epithelialisation, was carried out as follows: Firstly, a beaker containing distilled water was heated to 80°e. The thawed vaginal mucosa specimens were then dipped into the beaker for 30s, using tweezers. Upon removal of the tissue from the water, the uppermost layer was peeled off using another pair of tweezers. These de-epithelialised tissue samples were then cut into 7 pieces, -lmm? each, for loading into the donor compartments of the flow-through perfusion apparatus.
Calculation ofFlux Values
Flux values (1) across the membranes were calculated using the following relationship J = Q / A x t (dpm x em? x min ") Where Q is the quantity of substance crossing membrane (in dpm); A is the area of the membrane exposed (in ern"), and t is the time of exposure (in min).
Steady-State Kinetics A specific specimen and tritiated permeant were considered to have reached steady state when no statistically significant differences (P<0.05, t-test) were obtained, over at least 2 consecutive time intervals, between flux values.
Statistical Analysis
The GraphPad Prism, Version 4, 2003 computer programme was used to carry out non-linear regression analyses (third order polynomials). To compare flux rate versus time curves, statistical analyses were carried out using an F-test (15) .
Histological Assessment
Sections of mucosal specimens before (control) and after mechanical as well as heat de-epithelialisation, were subjected to routine histological examination using paraffin-embedded 5-flm sections stained with haematoxylin and eosin.
RESULTS
The Fig. 1 shows that the mean estimated flux values for Tac (599 ± 44 dpm. cnr-.mirr') were greater than those for CsA (96 ± 5.0 dpm.crrr-imin"). Whole curve comparison indicated statistically significant differences (P = 1.77xlO· 163 ) .
Mechanical de-epithelialisation of the vaginal mucosa (Fig. 2) resulted in an increased permeability of the mucosa to Tac, but not to CsA. The mean estimated flux value for Tac across mechanically deepithelialised mucosa was 932 ±137 dpm.cmLmin', and for Tac across the intact mucosa was 982 ± 115 dpm.cms.min'. For CsA, the mean estimated flux value across mechanically de-epithelialised mucosa was 158 ± 18 dpm.cmt.min' and across intact mucosa, 152 ± 19 dpm.cmtmin'.
Heat de-epithelialisation of the mucosa (Fig.  3 ) resulted in the following mean estimated flux values: 863 ± 83 dprn.cmi.min' for Tac across intact mucosa, 1117 ± 134 dpm.cmtmin' for Tac across heat de-epithelialised mucosa, 169 ± 18 dpm.cmLmin' for CsA across intact mucosa, and 185 ± 24 dpm.cm-.min' for CsA across heat de-epithelialised mucosa, respectively. There was a statistically significant difference between the mean estimated steady-state flux values for Tac; the heat de-epithelialised mucosa showing a greater permeability for Tac. CsA did not show as great a difference, but the heat de-epithelialised mucosae did show slightly greater permeability.
Histological examination of formalin-fixed sections of intact mucosal specimens (Fig. 4a ) as well as mucosal specimens after mechanical and heat de-epithelialisation showed that after the latter processes, removal of the epithelium was virtually complete (Figs. 4b and c). Isolated islands of epithelial cells remained attached to the connective tissue (lamina propria), a feature which was more pronounced for the mechanical (Fig. 4b ) than for the heat (Fig. 4c ) de-epithelialised tissue in the majority of sections examined. Furthermore, an abundance of basal cells was observed for the mechanically de-epithelialised mucosa. DISCUSSION
The advantages of topically administering drugs via routes other than per os are numerous. Mucosal delivery avoids gastrointestinal and hepatic first-pass effects and is, in the case of vaginal and buccal tissue, a convenient site to access allowing prolonged dosing Time(h) decrease in permeability of CsA across the mucosa. As mentioned earlier, CsA is an oligopeptide and we can therewith assume that it carries somewhat of a residual positive charge. It will therefore interact favourably with the negatively charged groups in the upper layers of the mucosa, and CsA molecules would have to redistribute from these superficial layers before being able to diffuse into deeper tissue regions,
The graphs depicting the two de-epithelialisation methods show an increase in permeability of the human vaginal mucosa to the two drugs, indicating that damaged mucosa is more permeable than intact mucosa (Figs. 2 and 3) . This supports the concept that the main mucosal permeability barrier to drug diffusion is situated in the upper layers of the epithelium (14) . Furthermore, this observation has clinical implications in that mucosa, from which the epithelium has sloughed off due to a disease process, will be significantly more permeable to topically applied drugs, potentially enhancing the healing process. The difference in permeability of Tac across heat de-epithelialised mucosa was more pronounced than across the mechanically de-epithelialised tissue. When comparing the effects of the two deepithelialisation methods on CsA permeability, heat de-epithelialisation also resulted in a greater CsA permeation than mechanical de-epithelialisation. This indicates that heat de-epithelialisation of a mucosal surface is a more efficient method to improve permeability ofa substance across that surface. This is most likely due to the fact that heat de-epithelialisation is a more effective means for removing the epithelial layer. When performing this method, one can visibly see the entire epithelial layer peeling off, whereas with mechanical de-epithelialisation, the effect is less easily discemable. Additionally, folds in the mucosal tissue may hinder complete removal of the epithelium with a scalpel. Also, one might not remove as much epithelium, because one wants to be careful not to damage the mucosal specimen deeper than the epithelial layer" which would render it far more permeable to molecules of any size. These effects which explain the higher. efficacy of heat vs mechanical de-epithelialisation is supported by the histological data ( Figs. 4b and c) .
No significant increases in the permeability of the vaginal mucosa to CsA were found when tissues were regimens at lower daily doses and continuous release oftherapeutically active compounds from appropriate delivery vehicles/devices. Furthermore, topical administration of drugs at the sites where mucosal lesions occur, reduces the side-effect profiles of these agents.
The statistically significant differences between the mean estimated steady-state flux values ofTac and CsA across intact human vaginal mucosa showed that human vaginal mucosa was~6 x more permeable to Tac than to CsA and may be explained as follows (Fig. 1 ). The first factor to consider is the substantial difference in molecular weight between the two drugs. CsA has an almost 50% larger molecular weight (MW ratio 1:1.46) than Tac, leading to a corresponding mechanically or heat de-epithelialised. This could, once again, be due to the considerable molecular weight of CsA, indicating that even when the mucosal surface is damaged, the CsA molecules are just too large to make any real difference in the penetration characteristics of this compound into the underlying tissues. Neither of the two permeants reached steady state in the period of time that our studies were performed, i.e. 24 h. We speculate that this is due to the fact that both molecules are predominantly lipophilic. It was demonstrated in a previous study that stacked intercellular lipid lamellae and membrane-bound intracellular granules containing internal lamellae occur within human vagin al mucosa (12) . These lamellae are composed of relatively non-reactive lipids; we speculate that it is this lipoidal layer that con stitutes the main epithelial permeability barrier to chemical substances through the mucosa.
In conclusion, both CsA and Tac traverse vaginal mucosa well. Considering that most drugs in clinical use possess molecular weights lower than 400 Da, this is a significant finding. Furthermore, we have demonstrated that heat de-epithelialisation is a superior method to mechanical de-epithelialisation for removing the epithelium of the mucosal tissue. Intralesional penetration of drugs may therefore be enhanced. The superior diffusion characteristics of Tac vs CsA and its higher potency may be clinically significant and tran slate into a much greater therapeutic efficacy of the former compound, compared to the latter.
